Acoustic neuroma diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Acoustic neuroma}} {{CMG}}; {{AE}} == Overview == == Diagnostic Study of Choice == === Study of choice === [Name of the investigation] is the gold standard test...")
 
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Acoustic neuroma}}
{{Acoustic neuroma}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}}{{M.B}}
== Overview ==
== Overview ==
[[Gadolinium]]-enhanced [[Magnetic resonance imaging|MRI scan]] is the definitive [[diagnostic test]] for acoustic neuroma and can identify [[tumors]] as small as 1-2 millimeter in [[diameter]]. On [[brain]] [[Magnetic resonance imaging|MRI]], acoustic neuroma characterized by hypointense mass on T1-weighted [[Magnetic resonance imaging|MRI]], and hyperintense mass on T2-weighted [[Magnetic resonance imaging|MRI]].


== Diagnostic Study of Choice ==
== Diagnostic Study of Choice ==
*[[Gadolinium]]-enhanced [[magnetic resonance imaging|magnetic resonance imaging (MRI)]]  is the preferred [[diagnostic test]] for identifying acoustic neuroma and can identify [[tumors]] as small as 1-2 millimeter in [[diameter]].<ref>{{Cite journal
| author = [[E. P. Lin]] & [[B. T. Crane]]
| title = The Management and Imaging of Vestibular Schwannomas
| journal = [[AJNR. American journal of neuroradiology]]
| volume = 38
| issue = 11
| pages = 2034–2043
| year = 2017
| month = November
| doi = 10.3174/ajnr.A5213
| pmid = 28546250
}}</ref><ref>{{Cite journal
| author = [[D. F. Wilson]], [[R. S. Hodgson]], [[M. F. Gustafson]], [[S. Hogue]] & [[L. Mills]]
| title = The sensitivity of auditory brainstem response testing in small acoustic neuromas
| journal = [[The Laryngoscope]]
| volume = 102
| issue = 9
| pages = 961–964
| year = 1992
| month = September
| doi = 10.1288/00005537-199209000-00001
| pmid = 1518359
}}</ref>


=== Study of choice ===
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center"
[Name of the investigation] is the gold standard test for the diagnosis of [disease name].
| valign="top" |
 
|+
OR
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|MRI component}}
 
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Features}}
The following result of [gold standard test] is confirmatory of [disease name]:
|-
* [Result 1]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
* [Result 2]
:T1
 
| style="padding: 5px 5px; background: #F5F5F5;" |
OR
*Slightly hypointense to the adjacent [[brain]] (63%)
 
*Isointense to the adjacent [[brain]] (37%)
[Name of the investigation] must be performed when:
*May contain hypointense [[Cyst|cystic]] areas
* The patient presents with [symptom/sign 1], [symptom/sign 2], and [symptom/sign 3].
|-
* A [name of test] is positive for [sign 1], [sign 2], and [sign 3] in the patient.
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
 
:T2
OR
| style="padding: 5px 5px; background: #F5F5F5;" |
 
*[[Heterogeneous|Heterogeneously]] hyperintense to the adjacent [[brain]]
[Name of the investigation] is the gold standard test for the diagnosis of [disease name].
*[[Cyst|Cystic]] areas [[fluid]] intensity
 
*May have associated peritumoral [[Arachnoid mater|arachnoid]] [[Cyst|cysts]]
OR
 
The diagnostic study of choice for [disease name] is [name of the investigation].
 
OR
 
There is no single diagnostic study of choice for the diagnosis of [disease name].
 
OR
 
There is no single diagnostic study of choice for the diagnosis of [disease name], but [disease name] can be diagnosed based on [name of the investigation 1] and [name of the investigation 2].
 
OR
 
[Disease name] is primarily diagnosed based on the clinical presentation.
 
OR
 
Investigations:
* Among the patients who present with clinical signs of [disease name], the [investigation name] is the most specific test for the diagnosis.
* Among the patients who present with clinical signs of [disease name], the [investigation name] is the most sensitive test for diagnosis.
* Among the patients who present with clinical signs of [disease name], the [investigation name] is the most efficient test for diagnosis.
 
==== The comparison of various diagnostic studies for [disease name] ====
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | Test
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Sensitivity
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Specificity
|-
|-
! style="background: #696969; color: #FFFFFF; text-align: center;" |Test 1
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |...%
:T1 C+ (Gd)
| style="background: #DCDCDC; padding: 5px; text-align: center;" |...%
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Contrast medium|Contrast]] enhancement is vivid
*But [[heterogeneous]] in larger [[Tumor|tumors]]
|-
|-
! style="background: #696969; color: #FFFFFF; text-align: center;" |Test 2
| style="background: #DCDCDC; padding: 5px; text-align: center;" |...%
| style="background: #DCDCDC; padding: 5px; text-align: center;" |...%
|}
|}
<small> [Name of test with higher sensitivity and specificity] is the preferred investigation based on the sensitivity and specificity</small>
===== Diagnostic results =====
The following finding(s) on performing [investigation name] is(are) confirmatory for [disease name]:
* [Finding 1]
* [Finding 2]
===== Sequence of Diagnostic Studies =====
The [name of investigation] must be performed when:
* The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
* A positive [test] is detected in the patient, to confirm the diagnosis.
OR
The various investigations must be performed in the following order:
* [Initial investigation]
* [2nd investigation]
=== Name of Diagnostic Criteria ===
'''It is recommended that you include the criteria in a table. Make sure you always cite the source of the content and whether the table has been adapted from another source.'''
[Disease name] is primarily diagnosed based on clinical presentation. There are no established criteria for the diagnosis of [disease name].
OR
There is no single diagnostic study of choice for [disease name], though [disease name] may be diagnosed based on [name of criteria] established by [...].
OR
The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
OR
The diagnosis of [disease name] is based on the [criteria name] criteria, which includes [criterion 1], [criterion 2], and [criterion 3].
OR
[Disease name] may be diagnosed at any time if one or more of the following criteria are met:
* Criteria 1
* Criteria 2
* Criteria 3
OR
'''IF there are clear, established diagnostic criteria'''
The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
OR
The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].
OR
The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].
OR
'''IF there are no established diagnostic criteria'''


There are no established criteria for the diagnosis of [disease name].
Post-op [[Magnetic resonance imaging|MRI]]: Linear enhancement may not indicate [[tumor]]. But if there is [[Nodule (medicine)|nodular]] enhancement, suspect [[tumor]] recurrence which will necessitate follow-up [[Magnetic resonance imaging|MRI]].<ref name="radio">Acoustic Schwannoma. Radiopedia(2015) http://radiopaedia.org/articles/acoustic-schwannoma Accessed on October 2 2015</ref>


===Staging===
[[File:Intracanalicular_acoustic_schwannoma.jpg|thumb|none|200px|[[Magnetic resonance imaging|MRI]] showing Intracanalicular acoustic neuroma<ref>Image courtesy of Dr Frank Gaillard. [http://www.radiopaedia.org Radiopaedia] (original file [http://radiopaedia.org/cases/intracanalicular-acoustic-schwannoma here]).[http://radiopaedia.org/licence Creative Commons BY-SA-NC</ref>]]
[[File:Intrameatal vestibularis schwannoma.jpg|thumb|none|200px|[[Magnetic resonance imaging|MRI]] showing [[Internal auditory meatus|Intrameatal]] vestibular schwannoma<ref>Image courtesy of  Dr. Roberto Schubert [http://www.radiopaedia.org Radiopaedia] (original file [http://radiopaedia.org/cases/intrameatal-vestibularis-schwannoma here]).[http://radiopaedia.org/licence Creative Commons BY-SA-NC</ref>]]


==References==
==References==

Latest revision as of 18:05, 26 April 2019

Acoustic neuroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acoustic neuroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acoustic neuroma diagnostic study of choice On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acoustic neuroma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acoustic neuroma diagnostic study of choice

CDC on Acoustic neuroma diagnostic study of choice

Acoustic neuroma diagnostic study of choice in the news

Blogs on Acoustic neuroma diagnostic study of choice

Directions to Hospitals Treating Acoustic neuroma

Risk calculators and risk factors for Acoustic neuroma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohsen Basiri M.D.

Overview

Gadolinium-enhanced MRI scan is the definitive diagnostic test for acoustic neuroma and can identify tumors as small as 1-2 millimeter in diameter. On brain MRI, acoustic neuroma characterized by hypointense mass on T1-weighted MRI, and hyperintense mass on T2-weighted MRI.

Diagnostic Study of Choice

MRI component Features
T1
  • Slightly hypointense to the adjacent brain (63%)
  • Isointense to the adjacent brain (37%)
  • May contain hypointense cystic areas
T2
T1 C+ (Gd)

Post-op MRI: Linear enhancement may not indicate tumor. But if there is nodular enhancement, suspect tumor recurrence which will necessitate follow-up MRI.[3]

MRI showing Intracanalicular acoustic neuroma[4]
MRI showing Intrameatal vestibular schwannoma[5]

References

  1. E. P. Lin & B. T. Crane (2017). "The Management and Imaging of Vestibular Schwannomas". AJNR. American journal of neuroradiology. 38 (11): 2034–2043. doi:10.3174/ajnr.A5213. PMID 28546250. Unknown parameter |month= ignored (help)
  2. D. F. Wilson, R. S. Hodgson, M. F. Gustafson, S. Hogue & L. Mills (1992). "The sensitivity of auditory brainstem response testing in small acoustic neuromas". The Laryngoscope. 102 (9): 961–964. doi:10.1288/00005537-199209000-00001. PMID 1518359. Unknown parameter |month= ignored (help)
  3. Acoustic Schwannoma. Radiopedia(2015) http://radiopaedia.org/articles/acoustic-schwannoma Accessed on October 2 2015
  4. Image courtesy of Dr Frank Gaillard. Radiopaedia (original file here).[http://radiopaedia.org/licence Creative Commons BY-SA-NC
  5. Image courtesy of Dr. Roberto Schubert Radiopaedia (original file here).[http://radiopaedia.org/licence Creative Commons BY-SA-NC

Template:WH Template:WS